Vitel also has Mexican territorial rights through licensing agreements with Cheplapharm Arzneimittel GmbH for Vesanoid
(for cancer); Kamada for KamRab (for rabies), KamRho (an Rh immunization) and Glassia (for Anti-D deficiency); Aqvida for Imatinib (for cancer), Docetaxel (for cancer), Azathriopine (an immunosuppressive drug); and QPharma for Androferti (a male fertility drug).
According to the contract, DKSH will be responsible for providing registration, importation, warehousing, physical distribution and collection services for Cheplapharm's products Vesanoid
(Tretinoin) and Rohypnol (Flunitrazepam) in Brunei, Hong Kong, Korea, Laos, Malaysia, Singapore, Thailand, and Vietnam.
Calcium Salt) Eposin Etoposide Injection 20mg/ml Vincristine Vincristine Injection 2mg/2ml in Vial Vincristine Vincristine Injection 10mg/Vial Avastin Bevacizumab Injection 25mg/ml Cisplatin Cisplatin Injection 50mg/Vial Platosin Cisplatin Injection 10mg in 10ml Vial Taxotere Docetaxel Injection 20mg/Vial Glivec Imatinib Capsule 100mg/Capsule Campto Trinotecan Injection 2ml/Vial Paclitaxel Paclitaxel Injection 30mg/5ml in Vial Taxol Paclitaxel Injection 30mg/5ml in Vial Vesanoid
Retinoic Acid Capsule 10mg/Capsule Herceptin Trastuzumab Injection 440mg/Vial Tmuran Azathioprine Tablet 50mg/Tablet Cellcept Mycophenolate Tablet 500mg/Tablet Mofetil Neoral Cyclosporin Capsule 25.
Among these include the rights to Vesanoid
(tretinoin), an oral retinoid anti-cancer chemotherapy drug licensed from Germany-based Cheplapharm Arzneimittel GmbH.
Tretinoin capsules is the generic version of Vesanoid
capsules and is used in the treatment of acute promyelocytic leukemia.